Pittsburgh, PA, June 27, 2017 -- TeleTracking Technologies, Inc. (“TeleTracking”) was named as the clear leader for overall performance in a new study,Patient Flow 2017 – No Reason to Wait, released by KLAS, a global healthcare research firm. Finding ways to effectively manage the flow of patients from admission through discharge is one of the most important challenges facing healthcare institutions today, and the reason why having a robust patient flow solution is an essential component to any health system’s quality optimization strategy.
As a highly respected third-party research firm, KLAS evaluates healthcare IT vendors annually and rates them broadly by customer satisfaction – using a consistent question set across all tracked segments. TeleTracking has been ranked number one and Best in KLAS for Patient Flow for the past six years*. The unique aspect to this most current study pertains to KLAS’s specific deep dive into patient flow and the role it plays in driving specific outcomes. Using these criteria, providers have yet again shared that they are more satisfied with TeleTracking than with any other patient flow vendor.
TeleTracking continues to help providers increase capacity and reduce patient wait times better than any other vendor in the study. The study also illustrates that TeleTracking leads not only in overall satisfaction, but also in the satisfaction of operational and clinical staff—the people who rely most heavily on patient flow functionality.
Providers also universally praised the available reporting tools, along with the solution’s automatic discharge and transport features that allow organizations to decrease manual input and further reduce patient wait times.
“While we are pleased to be so favorably positioned in this recent study, we are even more pleased with the growing recognition of patient flow as a strategic imperative if our healthcare system is to prosper over the long term,” says Kris Kaneta, Chief Marketing Officer. “Also, I would be remiss if I did not recognize the dozens of TeleTracking clients who participated in this study who, in partnership with TeleTracking, have dramatically increased health system capacity, decreased patient wait times, and ultimately improved patient access to care. They are the true winners of this study.”
*2011-2017 Best in KLAS: Software and Services, © KLAS Research, All Rights Reserved
About TeleTracking Technologies, Inc.
TeleTracking, the world leader in patient flow solutions believes no patient should ever have to wait for the care they need. Founded in Pittsburgh over a quarter of a century ago, TeleTracking delivers extraordinary outcomes that have been the subject of study by the RAND Corporation, and is the perennial KLAS Patient Flow Category Leader. To learn more, visit www.teletracking.com and follow us on social media.
About KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling healthcare organizations, including providers and payers, to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services and medical equipment to deliver timely reports, trends and practical overviews. The research directly represents the provider and payers’ voice acting as a catalyst for improving vendor performance. To learn more about KLAS and our reports, visit www.KLASresearch.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3c51df29-169f-4458-85d7-61196e424c4f
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1a57d153-eeed-46ac-848f-68181ee26cb7
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a1113c23-a2ec-44a2-ae04-fbfe03fce78c
Amie Podolak Teletracking Technologies Inc 412-391-6395 [email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anta Sports Expands Global Footprint With Strategic Puma Stake
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



